nifedipine has been researched along with bromocriptine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Pratim Roy, P; Roy, K | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M | 1 |
| Brostrom, CO; Brostrom, MA; Wolfe, SE | 1 |
| Bélisle, S; Petit, A; Vaillancourt, C | 1 |
| Caccavelli, L; Chuang, TT; Enjalbert, A; Kordon, C | 1 |
| Hopp, L; Iffy, L; Weisse, AB | 1 |
| Chang, LL; Chen, JJ; Chiao, YC; Huang, WJ; Kan, SF; Kau, MM; Lin, H; Lo, MJ; Tsai, SC; Wang, JL; Wang, PS; Wun, WS; Yeh, JY | 1 |
1 review(s) available for nifedipine and bromocriptine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for nifedipine and bromocriptine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Topics: Algorithms; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Factor Analysis, Statistical; Least-Squares Analysis; Linear Models; Models, Molecular; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Reproducibility of Results | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Bromocriptine; Dopamine; Female; Humans; Metoclopramide; Neoplasms, Multiple Primary; Nifedipine; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Mechanisms of action of inhibitors of prolactin secretion in GH3 pituitary cells. I. Ca2+-dependent inhibition of amino acid incorporation.
Topics: Acetylcholine; Amino Acids; Animals; Bromocriptine; Calcium; Carbachol; Cell Line; Chlorpromazine; Imidazoles; Magnesium; Nifedipine; Pituitary Neoplasms; Prolactin; Protein Processing, Post-Translational; Rats; Trifluoperazine; Verapamil | 1986 |
Inhibition of angiotensin II-stimulated inositol phosphate production by D2-dopamine receptor is calcium-dependent in human trophoblastic cells.
Topics: Angiotensin II; Bromocriptine; Calcium; Cells, Cultured; Colforsin; Cyclic AMP; Dopamine; Humans; In Vitro Techniques; Inositol Phosphates; Nifedipine; Receptors, Dopamine D2; Trophoblasts | 1995 |
Protein kinase C regulation of prolactin gene expression in lactotroph cells: involvement in dopamine inhibition.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Bromocriptine; Cells, Cultured; Colforsin; Cyclic AMP; Dopamine; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Kinetics; Nifedipine; Pituitary Gland, Anterior; Potassium; Prolactin; Protein Kinase C; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors | 1993 |
Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression.
Topics: Adult; Bromocriptine; Coronary Vasospasm; Dose-Response Relationship, Drug; Female; Humans; Lactation; Myocardial Infarction; Nifedipine; Pregnancy; Puerperal Disorders | 1996 |
Direct effects of prolactin on corticosterone release by zona fasciculata-reticularis cells from male rats.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Animals; Bromocriptine; Cells, Cultured; Cerebral Cortex; Colforsin; Corticosterone; Cyclic AMP; Desoxycorticosterone; Hyperprolactinemia; Injections, Subcutaneous; Male; Nifedipine; Pituitary Gland, Anterior; Pregnenolone; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley; Sheep; Zona Fasciculata; Zona Reticularis | 1999 |